Literature DB >> 2013827

Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.

P S Colloby1, K P West, A Fletcher.   

Abstract

We have assessed the degree of observer variation of both Breslow depth and Clark's level in a series of 50 thin malignant melanomas. Our findings are similar to those of previous international studies in the Breslow depth is the more reproducible measure. Significant intra- and inter-observer variation exists and in some cases it was up to +/- 0.86 mm. Even small differences will potentially affect patient management at our centre and this was analysed using kappa statistics. Good agreement was found between observers and this could be improved by comparing the mean of two or more measurements. This removes larger errors, but smaller observer errors and differences in subjective interpretation of the deepest malignant cell mean that agreement will never be more than 90 per cent. This is high compared with studies of observer variation in other pathological conditions, e.g., dysplasia of the cervix, but where surgical management is potentially disfiguring it is not high enough. We conclude that Breslow depth and Clark's level should not be the sole basis of wide excision protocols.

Entities:  

Mesh:

Year:  1991        PMID: 2013827     DOI: 10.1002/path.1711630310

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Authors:  Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan R Knezevich; Patricia A Carney; Lisa M Reisch; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2013-10-28       Impact factor: 11.527

2.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

3.  Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?

Authors:  Laura A Taylor; Megan M Eguchi; Lisa M Reisch; Andrea C Radick; Hannah Shucard; Kathleen F Kerr; Michael W Piepkorn; Stevan R Knezevich; David E Elder; Raymond L Barnhill; Joann G Elmore
Journal:  Cancer       Date:  2021-05-04       Impact factor: 6.860

4.  The velocity of ultrasound in human primary melanoma tissue - implications for the clinical use of high resolution sonography.

Authors:  M Weichenthal; P Mohr; E W Breitbart
Journal:  BMC Dermatol       Date:  2001-06-28

5.  Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Authors:  Joann G Elmore; Raymond L Barnhill; David E Elder; Gary M Longton; Margaret S Pepe; Lisa M Reisch; Patricia A Carney; Linda J Titus; Heidi D Nelson; Tracy Onega; Anna N A Tosteson; Martin A Weinstock; Stevan R Knezevich; Michael W Piepkorn
Journal:  BMJ       Date:  2017-06-28

6.  Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual.

Authors:  Joann G Elmore; David E Elder; Raymond L Barnhill; Stevan R Knezevich; Gary M Longton; Linda J Titus; Martin A Weinstock; Margaret S Pepe; Heidi D Nelson; Lisa M Reisch; Andrea C Radick; Michael W Piepkorn
Journal:  JAMA Netw Open       Date:  2018-05

Review 7.  Current state of melanoma diagnosis and treatment.

Authors:  Lauren E Davis; Sara C Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2019-08-01       Impact factor: 4.742

8.  Pathologists' agreement on treatment suggestions for melanocytic skin lesions.

Authors:  Mustufa A Jafry; Sue Peacock; Andrea C Radick; Hannah L Shucard; Lisa M Reisch; Michael W Piepkorn; Stevan R Knezevich; Martin A Weinstock; Raymond L Barnhill; David E Elder; Kathleen F Kerr; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2019-12-17       Impact factor: 11.527

9.  Problems with registration of cutaneous malignant melanoma in England.

Authors:  J Melia; T Frost; R Graham-Brown; J Hunter; A Marsden; A du Vivier; A P Warin; J White; S Whitehead; M Wroughton
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.